Skip to main content
. 2021 Jul 27;8:689507. doi: 10.3389/fcvm.2021.689507

Table 3.

Short-term Prognosis.

Overall Propensity score matched
TAR with FET (n = 518) Hybrid surgery (n = 31) P-value TAR with FET (n = 44) Hybrid surgery (n = 23) P-value
Ventilation time (hours) 39.0 (86.5) 41.0 (104.0) 0.724 70.0 (119.5) 43.0 (105.5) 0.461
ICU stays (days) 3.29 (5.42) 5.00 (8.46) 0.205 4.71 (7.50) 5.00 (8.46) 0.966
Hospitalization days (days) 18.0 (15.0) 21.0 (15.0) 0.181 22.0 (19.8) 21.0 (18.0) 0.737
Post-operative complications (%) 99 (19.1%) 11 (35.5%) 0.027 11 (25.0%) 9 (39.1%) 0.230
  Permanent neurological complications (%) 29 (5.6%) 8 (25.8%) 0.001 1 (2.3%) 6 (26.1%) 0.005
    Cerebral infarction (%) 12 (2.3%) 7 (22.6%) <0.001 0 (0.0%) 5 (21.7%) 0.003
    Cerebral hemorrhage (%) 9 (1.7%) 1 (3.2%) 0.444 1 (2.3%) 1 (4.3%) 1.000
    Hemiplegia (%) 8 (1.5%) 0 (0.0%) 1.000 0 (0.0%) 0 (0.0%) -
  Transient neurological complications (%) 10 (1.9%) 0 (0.0%) 1.000 1 (2.3%) 0 (0.0%) 1.000
  Acute renal failure (%) 76 (14.7%) 5 (16.1%) 0.795 8 (18.2%) 4 (17.4%) 1.000
  Permanent hemodialysis (%) 8 (1.5%) 1 (3.2%) 0.410 0 (0.0%) 1 (4.3%) 0.343
  Acute liver failure (%) 16 (3.1%) 1 (3.2%) 1.000 1 (2.3%) 0 (0.0%) 1.000
  Low cardiac output syndrome (%) 21 (4.1%) 0 (0.0%) 0.623 1 (2.3%) 0 (0.0%) 1.000
  Pulmonary infection (%) 58 (11.2%) 1 (3.2%) 0.235 4 (9.1%) 1 (4.3%) 0.653
  Tracheostomy (%) 18 (3.5%) 1 (3.2%) 1.000 4 (9.1%) 1 (4.3%) 0.653
  Reoperation (%) 38 (7.3%) 0 (0.0%) 0.156 6 (13.6%) 0 (0.0%) 0.087
  Reoperation for bleeding (%) 22 (4.2%) 0 (0.0%) 0.628 3 (6.8%) 0 (0.0%) 0.546
  30-day mortality (%) 55 (10.6%) 3 (9.7%) 1.000 7 (15.9%) 3 (13.0%) 1.000
  In-hospital mortality (%) 41 (7.9%) 3 (9.7%) 0.730 7 (15.9%) 3 (13.0%) 1.000

ICU, Intensive Care Unit. The categorical variables in the table are presented by the number of cases (with percentage) and the continuous variables are expressed by the median (with interquartile range).